History video History video Learn more about the history of the innovative pharmaceutical company Boehringer Ingelheim
The GPP Forum Report The GPP Forum Report The generalized pustular psoriasis (GPP) Forum Report summarizes and highlights the important moments form the multistakeholder GPP Forum
Rare Diseases: Rare but not alone Rare Diseases: Rare but not alone We are committed to listen and learn from patients with rare diseases to deliver breakthrough therapies.
Helping smallholder farmers after Covid-19 Helping smallholder farmers after Covid-19 In Ghana, we are helping smallholder farmers overcome hardship caused by the pandemic.
Practical Advice Practical Advice Practical advice for people with type 2 diabetes (T2D) at risk of heart disease
How BI Supports Grass Roots Innovation How BI Supports Grass Roots Innovation Hear from life-science entrepreneurs about how we are supporting early-stage science through our innovative Grass Roots program.
Professor Richeldi treatment initiation Professor Richeldi treatment initiation Leading pulmonologist Professor Richeldi discusses why early initiation of treatment in Idiopathic Pulmonary Fibrosis is important.
Systemic sclerosis - Ilaria's story Systemic sclerosis - Ilaria's story Watch Ilaria talk about her journey living with systemic sclerosis
IPF treatment discussions IPF treatment discussions Listen to Steve Jones (a person living wih IPF) and Dr. Marlies Wijsenbeek (a leading pulmonologist) discuss the importance of treatment discussions in IPF
Pet parasites are still here. What's the risk? Pet parasites are still here. What's the risk? What's the risk of pet parasites? They’re a growing challenge due to climate change. Check how to protect your dog and cat from fleas, ticks and more.
Cooperation with The Defeat-NCD Partnership Cooperation with The Defeat-NCD Partnership Together with The Defeat-NCD Partnership, Boehringer Ingelheim aims to address key access to healthcare issues related to non-communicable diseases.
L'Arte di Respirare IN IPF L'Arte di Respirare IN IPF Expert Prof. Richeldi discusses the link between Idiopathic Pulmonary Fibrosis (IPF) and Leonardo da Vinci and importance of taking action early.
How Boehringer Ingelheim is Supporting Grass Roots Innovation How Boehringer Ingelheim is Supporting Grass Roots Innovation Our Grass Roots activities support life-science innovators with mentoring and networking opportunities.
Ivan Blanarik Therapeutic Area Head Respiratory Ivan Blanarik Therapeutic Area Head Respiratory Ivan Blanarik, Therapeutic Area Head Respiratory at Boehringer Ingelheim
importance of velcro-like crackles in IPF diagnosis importance of velcro-like crackles in IPF diagnosis Dr. Bonella, Rare Lung Disease Specialist, discusses the importance of accurate & early diagnosis inIdiopathic Pulmonary Fibrosis
Introduction to head-to-head trials Introduction to head-to-head trials Hear from experts Dr Kerr and Dr Melosky.
Four Pillars Cancer Immunology Four Pillars Cancer Immunology Boehringer Ingelheim is focusing cancer immunology research on T cell engagers, cancer vaccines, oncolytic viruses and immune & stromal modulation
Lung Repair & Regeneration Video Lung Repair & Regeneration Video Lung repair & regeneration research addresses fundamental changes to lung architecture and how these changes impact lung function.
Boehringer Ingelheim Academy Video 2023 Boehringer Ingelheim Academy Video 2023 Boehringer Ingelheim’s Academy initiative provides networking opportunities, education and facilitates conversations across the innovation community.
Rafael Sani Simoes Rafael Sani Simoes Learn how Rafael’s role in Patient Safety enables him to make a difference.
Marie Penzold Marie Penzold Marie Penzold talks about her career as a HR business partner in the Innovation unit here at Boehringer Ingelheim.
biologicals-development-center biologicals-development-center Europe’s largest biotechnology center in Biberach, Germany is the home to three development units.
Lifelong learning Lifelong learning Discover how Boehringer Ingelheim values and encourages employee development.